Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetraethylene Glycol SCHEMBL29640412 | 0.89 | MEN1 (0.46) | MEN1KMT2ATSHRCYP4F2CYP4A11 | |
| Tetraethylene Glycol SCHEMBL23581563 | 0.89 | MEN1 (0.46) | MEN1KMT2ATSHRCYP4F2CYP4A11 | |
| SCHEMBL28372906 | 0.82 | TSHR (0.37) | TSHRCYP4F2CYP4A11 | |
| SCHEMBL15293617 | 0.82 | TSHR (0.37) | TSHRCYP4F2CYP4A11 | |
| SCHEMBL28527730 | 0.79 | HCAR2 (0.37) | TSHR | |
| SCHEMBL408792 | 0.76 | MEN1 (0.48) | MEN1KMT2ATSHRCYP4F2CYP4A11 | |
| SCHEMBL11109445 | 0.76 | MEN1 (0.48) | MEN1KMT2ATSHRCYP4F2CYP4A11 | |
| SCHEMBL28530635 | 0.76 | ALDH1A1 (0.44) | TSHRMAPK1 | |
| Ammonia Solution, Strong SCHEMBL28974944 | 0.74 | MEN1 (0.46) | MEN1KMT2ATSHRCYP4F2CYP4A11 | |
| Tetraethylene Glycol SCHEMBL4886960 | 0.73 | MEN1 (0.55) | MEN1KMT2ATSHRCYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110046127-A1 | Imidazopyridazines for Use as Protein Kinase Inhibitors | CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS (CNIO) (ES) | 2011-02-24 | — | — | US | claimed |
| EP-2217601-A1 | IMIDAZOPYRIDAZINES FOR USE AS PROTEIN KINASE INHIBITORS | Centro Nacional de Investigaciones Oncológicas (CNIO) (ES) | 2010-08-18 | — | — | EP | claimed |
| US-7652128-B2 | Toner composition | XEROX CORPORATION (US) | 2010-01-26 | — | — | US | claimed |
| US-20090142692-A1 | LOW MOLECULAR WEIGHT LATEX AND TONER COMPOSITIONS COMPRISING THE SAME | XEROX CORPORATION (US) | 2009-06-04 | — | — | US | claimed |
| WO-2009060197-A1 | IMIDAZOPYRIDAZINES FOR USE AS PROTEIN KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS (CNIO) (ES) | 2009-05-14 | — | — | WO | claimed |
| US-20060286476-A1 | manufactured under monomer-starved polymerization condition such as monomer feeding rate equal to or less than 0.516% per minute by weight of the monomer(s) to be fed; gloss, fusing performance, crease performance, stripping performance, document offset, vinyl offset, and parent charging etc. | XEROX CORPORATION | 2006-12-21 | — | — | US | claimed |
| US-20060100300-A1 | Toner composition | XEROX CORPORATION | 2006-05-11 | — | — | US | claimed |
| US-20240153687-A1 | COMPOSITION HAVING MAGNETOSTRICTIVE PROPERTIES, AND CURED PRODUCT THEREOF | TOHOKU UNIVERSITY (JP) | 2024-05-09 | — | — | US | disclosed |
| EP-4303244-A1 | COMPOSITION HAVING MAGNETOSTRICTIVE PROPERTIES, AND CURED PRODUCT THEREOF | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-01-10 | — | — | EP | disclosed |
| US-20230350318-A1 | IMAGE FORMING SYSTEM AND METHOD FOR FORMING IMAGE | Konica Minolta, Inc. (JP) | 2023-11-02 | — | — | US | disclosed |
| EP-3348623-B1 | PRESSURE-SENSITIVE ADHESIVE COMPOSITION, PROCESS FOR PRODUCING SAME, AND PRESSURE-SENSITIVE ADHESIVE FILM | MITSUI CHEMICALS TOHCELLO INC (JP) | 2023-10-11 | — | — | EP | disclosed |
| EP-4102302-A1 | TWO-COMPONENT DEVELOPER FOR ELECTROSTATIC CHARGE IMAGE DEVELOPMENT, ELECTROPHOTOGRAPHIC IMAGE FORMING METHOD AND ELECTROPHOTOGRAPHIC IMAGE FORMIG APPARATUS | KONICA MINOLTA, INC. (JP) | 2022-12-14 | — | — | EP | disclosed |
| US-20220390873-A1 | TWO-COMPONENT DEVELOPER FOR ELECTROSTATIC CHARGE IMAGE DEVELOPMENT, ELECTROPHOTOGRAPHIC IMAGE FORMING METHOD AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS | Konica Minolta, Inc. (JP) | 2022-12-08 | — | — | US | disclosed |
| WO-2000053649-A1 | STYRENIC GRAFT COPOLYMER AND METHOD OF PREPARING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2000-09-14 | — | — | WO | disclosed |
| US-6037054-A | SUPPORT HAVING RUBBER PRESSURE SENSITIVE ADHESIVE LAYER OF ISOBUTYLENE POLYMER | NITTO DENKO CORPORATION (JP) | 2000-03-14 | — | — | US | disclosed |
| EP-0947553-A2 | Pressure-sensitive adhesive and surface protecting material | NITTO DENKO CORPORATION (JP) | 1999-10-06 | — | — | EP | disclosed |
| EP-0839886-A2 | Sheet for protecting paint film | NITTO DENKO CORPORATION (JP) | 1998-05-06 | — | — | EP | disclosed |
| EP-0490269-B1 | Graft copolymer and process for producing the same | IDEMITSU KOSAN CO (JP) | 1996-02-28 | — | — | EP | disclosed |
| US-5250629-A | Graft polymerization of styrene and ethylenically unsaturated monomer using transition metal catalysts, organoaluminum compounds; films, packaging, automobile parts | IDEMITSU KOSAN CO., LTD. (JP) | 1993-10-05 | — | — | US | disclosed |
| EP-0490269-A1 | Graft copolymer and process for producing the same | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1992-06-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046127-A1 | Imidazopyridazines for Use as Protein Kinase Inhibitors | PIM1, PIM3, PIM2 | MEN1 2279/4885KMT2A 1247/4885TSHR 1138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.